Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
LC–MS strategies for advanced modalities: ADC, AOC, multidomain and RNA therapeutics 5 days 21 hours 51 mins 17 secs REGISTER NOW

The CAR-T cell therapy workflow

10 Jun 2019
Clinical

Find out more about the CAR-T cell therapy workflow in this informative infographic from Bio-Rad Laboratories (CA, USA). Discover some of the challenges associated with CAR-T cell R&D as well as technologies and reagents used for bioanalytical analysis.

CAR-T infographic (3)

CLICK HERE TO DOWNLOAD THE INFOGRAPHIC

Top content

  • Merck snaps up Terns Pharmaceuticals to expand its oncology pipeline
  • eBook: Precision bioanalysis for every molecule
  • Ask the Experts: quantifying translational biomarkers

Related tags

antibodies Bio-rad CAR-T cell therapy
Previous article Next article

Related articles

28 APR 2020 CLINICAL
COVID-19 and microsampling: from patient-centric testing to drug development and beyond
CAR T-cell therapy lymphodepletion chemotherapy
13 SEP 2023 NEWS
What if we could eliminate the need for lymphodepleting chemotherapy before CAR T-cell therapy?
15 JUL 2020 NEWS
Micro-lab on a chip can detect blood type within minutes
27 APR 2020 CLINICAL
Serological test developed for COVID-19
COVID-19 blood biomarkers for screening and treatment
21 JUN 2023 NEWS
COVID-19 antibodies detected by new adhesive bandage
Bispecific antibodies
26 FEB 2024 NEWS
Bispecific antibodies are ‘switching’ up immunotherapy
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone